- Home
- VTYX vs LGI Comparison
VTYX vs LGI Comparison
Compare VTYX & LGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- LGI
- Stock Information
- Founded
- VTYX 2018
- LGI 2004
- Country
- VTYX United States
- LGI United States
- Employees
- VTYX N/A
- LGI N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- LGI
- Sector
- VTYX Health Care
- LGI
- Exchange
- VTYX Nasdaq
- LGI Nasdaq
- Market Cap
- VTYX 184.6M
- LGI 219.9M
- IPO Year
- VTYX 2021
- LGI N/A
- Fundamental
- Price
- VTYX $2.30
- LGI $16.05
- Analyst Decision
- VTYX Buy
- LGI
- Analyst Count
- VTYX 5
- LGI 0
- Target Price
- VTYX $8.40
- LGI N/A
- AVG Volume (30 Days)
- VTYX 2.3M
- LGI 41.1K
- Earning Date
- VTYX 11-07-2024
- LGI 01-01-0001
- Dividend Yield
- VTYX N/A
- LGI 7.10%
- EPS Growth
- VTYX N/A
- LGI N/A
- EPS
- VTYX N/A
- LGI N/A
- Revenue
- VTYX N/A
- LGI N/A
- Revenue This Year
- VTYX N/A
- LGI N/A
- Revenue Next Year
- VTYX N/A
- LGI N/A
- P/E Ratio
- VTYX N/A
- LGI N/A
- Revenue Growth
- VTYX N/A
- LGI N/A
- 52 Week Low
- VTYX $1.67
- LGI $12.66
- 52 Week High
- VTYX $11.48
- LGI $16.68
- Technical
- Relative Strength Index (RSI)
- VTYX 47.68
- LGI 28.77
- Support Level
- VTYX $2.21
- LGI $15.75
- Resistance Level
- VTYX $2.54
- LGI $16.74
- Average True Range (ATR)
- VTYX 0.27
- LGI 0.22
- MACD
- VTYX -0.05
- LGI -0.10
- Stochastic Oscillator
- VTYX 8.02
- LGI 6.93
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About LGI Lazard Global Total Return and Income Fund
Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt, and others.